Securities Report – 72nd Fiscal Period (April 1, 2025 – March 31, 2026)
Key facts
- Securities Report – 72nd Fiscal Period (April 1, 2025 – March 31, 2026)
- Zeria Pharmaceutical Co., Ltd. has filed its Securities Report for the 72nd fiscal period (April 1, 2025 – March 31, 2026). This document provides comprehensive financial and management information as required by regulatory standards.
- Source: PR Times
- Date: June 25, 2026
Direct answer
Zeria Pharmaceutical Co., Ltd. has filed its Securities Report for the 72nd fiscal period (April 1, 2025 – March 31, 2026). This document provides comprehensive financial and management information as required by regulatory standards.
- Citation
- Securities Report – 72nd Fiscal Period (April 1, 2025 – March 31, 2026) (June 25, 2026), PR Times
- Source
- PR Times
- Date
- June 25, 2026
Zeria Pharmaceutical Co., Ltd. has filed its Securities Report for the 72nd fiscal period (April 1, 2025 – March 31, 2026). This document provides comprehensive financial and management information as required by regulatory standards.
📋 Article Processing Timeline
- 📰 Published: June 25, 2026 at 19:00
- 🔍 Collected: June 25, 2026 at 15:41
- 🤖 AI Analyzed: June 25, 2026 at 15:44 (2 min after Collected)
Zeria Pharmaceutical Co., Ltd. Securities Report – 72nd Fiscal Period (April 1, 2025 – March 31, 2026)
FAQ
What is the 72nd fiscal period for Zeria Pharmaceutical?
The 72nd fiscal period runs from April 1, 2025 to March 31, 2026.
What is a Securities Report?
A mandatory annual filing by listed companies disclosing financial and management information for investors.
What does Zeria Pharmaceutical do?
It develops, manufactures, and markets pharmaceuticals focused on gastrointestinal and CNS disorders.
Why is this report important for investors?
It provides key insights into financial performance, strategy, and risk factors for informed decision-making.
Where is Zeria Pharmaceutical headquartered?
The headquarters is located in Nihonbashi-Honcho, Chuo-ku, Tokyo.